About Us

Who we are: Partnership for the U.S. Life Science Ecosystem (PULSE)

PULSE is dedicated to raising awareness about the unique life sciences ecosystem and the importance of mergers & acquisitions (M&A) in empowering companies of all sizes to specialize in what they do best, and partner when it makes sense to advance new treatments and cures.

PULSE partners reflect the diversity and collaboration that makes the American life sciences ecosystem the most competitive and innovative in the world.

PULSE focuses on the role of M&A in three key areas of America’s life sciences industry:

M&A fuels innovation and competition across a diverse and dynamic life sciences ecosystem.

America’s life sciences industry is unique within the health care supply chain, with more than 2,800 life sciences companies headquartered in U.S., collectively focused on thousands of diverse diseases and treatment approaches. Every part of the ecosystem—from early-stage companies to academics to larger life sciences firms—depends on M&A to fuel innovation and develop new treatments and cures.

M&A drives innovation and facilitates the process of bringing new treatments and cures to market.

M&A makes it possible for companies pursuing important new therapies to accelerate progress and preserve competition, helping bring groundbreaking innovations from the lab to the patient. Research demonstrates that life sciences M&A significantly improves the odds of bringing new therapies launching for patients.

M&A powers America’s global leadership in life sciences innovation while fueling economic growth and jobs in every U.S. state.

Through long-standing partnerships between scientists and academics, early-stage companies, and more established life sciences companies, the U.S. has built the world’s leading innovation ecosystem. M&A is the lifeblood that supports—and incentivizes—these partnerships.